Tags : Honing Biosciences

Institut Curie Announces formation of Honing Biosciences for the Development

Shots: Honing Biosciences will use CellTune molecular technology, that will initially emphasize on cancer immunotherapies particularly the CAR-T cells to target cancer cells The focus on this launch is to provide long-term care for cancer patients using a single injection of therapeutic cells, with the development of safe, effective and affordable approaches CellTune molecular technology […]Read More